CAS 152684-53-2: L-Glutamyl-S-(benzyl)-L-cysteinyl-D-phenylglycine

TLK117 is an inhibitor of GSTs that reduces the severity of pulmonary fibrosis and may be used in the study of idiopathic pulmonary fibrosis.

TLK117 is a potent inhibitor of kinase, a protein that plays a crucial role in cancer cell growth and proliferation. This human oxytocin analog has been shown to induce apoptosis, or programmed cell death, in tumor cells. TLK117 is an anticancer drug that has demonstrated significant efficacy against various types of cancer in preclinical studies. It is particularly effective against Chinese hamster ovary cells and caffeine-treated urine cells. TLK117 works by inhibiting the activity of kinase, which leads to the suppression of cancer cell growth and proliferation. This inhibitor shows great promise as a novel therapeutic option for the treatment of cancer.